MarketInOut Stock Screener Log In | Sign Up

Profound Medical Corp

TSX • Healthcare • Medical Devices • Quote as of 10/27/2026 15:59
Profound Medical Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeTSX
Market Capitalization284.59 mln
Float35.50 mln
Earnings Date11/05/2026

Relative Strength

1 / 100
Severely lagging

Debt / Equity

0.15
Very low leverage

Pre-Tax Margin

-170%
Severely loss-making

ROE

-73.53
Deeply negative

ROA

-39.46
Deeply negative

Business Description

Profound Medical Corp. is a Canadian medical device company based in Mississauga that sells two non-surgical treatment systems guided by MRI technology. Its main product, TULSA-PRO, uses ultrasound energy delivered through the urethra to destroy prostate tissue ? whether cancerous or not ? while MRI imaging keeps the process precise and controlled in real time. Its second system, Sonalleve, applies the same MRI-guided approach to treat conditions such as uterine fibroids, bone pain from cancer, and certain benign tumors. The company serves patients across Canada, the United States, Germany, China, and Finland.

Key Fundamentals

EPS-1.37
ROE-73.53
RPS0.73
ROIC-60.49
ROA-39.46
EBITDA, mln-46.82
EV / EBITDA-5.16
Revenue, mln26.56

Quote Details

Last 7.88
Change 0.03 (0.38%)
Open 7.97
Volume 6,394
Turnover 50,385
Average Volume 14,339

Financial Ratios

Pre-Tax Profit Margin-170
Leverage Ratio1.25
Current Ratio6.46
Price / Book4.07
Debt / Equity0.15
Price / Sales10.71

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.4% 7 / 100   
1 Month -3.55% 31 / 100   
2 Months -17.92% 7 / 100   
6 Months -17.49% 13 / 100   
1 Year 6.63% 43 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog